Rationale for the Development of a Pentavalent Meningococcal Vaccine: A US-Focused Review Gary S. MarshallJaime FergiePaula Peyrani Review Open access 31 March 2022 Pages: 937 - 951
Interferon Treatments for SARS-CoV-2: Challenges and Opportunities Diya JhutiAngeli RawatJamie I. Forrest Review Open access 21 April 2022 Pages: 953 - 972
Legionnaires’ Disease: Update on Diagnosis and Treatment Diego ViasusValeria GaiaJordi Carratalà Review Open access 03 May 2022 Pages: 973 - 986
Estimates of the Health and Economic Burden of Pneumococcal Infections Attributable to the 15-Valent Pneumococcal Conjugate Vaccine Serotypes in the USA Kwame Owusu-EduseiArijita DebKelly D. Johnson Original Research Open access 27 January 2022 Pages: 987 - 999
Correction to: Estimates of the Health and Economic Burden of Pneumococcal Infections Attributable to the 15-Valent Pneumococcal Conjugate Vaccine Serotypes in the USA Kwame Owusu-EduseiArijita DebKelly D. Johnson Correction Open access 06 March 2022 Pages: 1001 - 1001
Clinical and Microbiological Characterization of Bloodstream Infections Caused by Mycoplasma hominis: An Overlooked Pathogen Tong ZengYuan WuXiaotuan Zhang Original Research Open access 14 March 2022 Pages: 1003 - 1017
A Nonlinear Time-Series Analysis to Identify the Thresholds in Relationships Between Antimicrobial Consumption and Resistance in a Chinese Tertiary Hospital Shixing ChenZepeng LiChao Wu Original Research Open access 15 March 2022 Pages: 1019 - 1032
Late cART Initiation Consistently Driven by Late HIV Presentation: A Multicenter Retrospective Cohort Study in Taiwan from 2009 to 2019 Chun-Yuan LeeYi-Pei LinPo-Liang Lu Original Research Open access 18 March 2022 Pages: 1033 - 1056
A Clinical Diagnostic Study: Fibulin-2 is a Novel Promising Biomarker for Predicting Infection Shidan LiHao JiangJun Fei Original Research Open access 18 March 2022 Pages: 1057 - 1073
Effectiveness of Favipiravir on Nonsevere, Early-Stage COVID-19 in Japan: A Large Observational Study Using the COVID-19 Registry Japan Shinya TsuzukiKayoko HayakawaNorio Ohmagari Original Research Open access 21 March 2022 Pages: 1075 - 1087
Risk Factors for Mortality Among Critical Acute Pancreatitis Patients with Carbapenem-Resistant Organism Infections and Drug Resistance of Causative Pathogens Di WuYilin HuangJie Peng Original Research Open access 04 April 2022 Pages: 1089 - 1101
Novel Naturally Occurring Dipeptides and Single-Stranded Oligonucleotide Act as Entry Inhibitors and Exhibit a Strong Synergistic Anti-HIV-1 Profile Rafael Ceña-DiezKamalendra SinghAnders Sönnerborg Original Research Open access 07 April 2022 Pages: 1103 - 1116
Interpretable Machine Learning for Early Prediction of Prognosis in Sepsis: A Discovery and Validation Study Chang HuLu LiBo Hu Original Research Open access 10 April 2022 Pages: 1117 - 1132
The Role of Metabolic Factors and Steatosis in Treatment-Naïve Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase Yuting DiaoDanqing HuQin Ning Original Research Open access 10 April 2022 Pages: 1133 - 1148
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors Federica BrianoLaura MagnascoMatteo Bassetti Original Research Open access 11 April 2022 Pages: 1149 - 1160
Evaluation of the Dynamiker® Fungus (1–3)-β-d-Glucan Assay for the Diagnosis of Invasive Aspergillosis in High-Risk Patients with Hematologic Malignancies Maria SiopiStamatis KarakatsanisJoseph Meletiadis Original Research Open access 11 April 2022 Pages: 1161 - 1175
Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort Ramón TeiraHelena Diaz-CuervoAdriá Currán Original Research Open access 11 April 2022 Pages: 1177 - 1192
Pursuing Elimination of Hepatitis C in Egypt: Cost-Effectiveness and Economic Evaluation of a Country-Wide Program Bjoern SchwanderJosh FeldsteinMohamed Hassany Original Research Open access 22 April 2022 Pages: 1193 - 1203
Clinical Relevance of Xpert MRSA/SA in Guiding Therapeutic Decisions for Staphylococcal Infections: A Diagnostic Test Accuracy Analysis Suvash Chandra OjhaKe ChenCun-Liang Deng Original Research Open access 22 April 2022 Pages: 1205 - 1227
Patients with COVID-19 and HBV Coinfection are at Risk of Poor Prognosis Shanshan YangShengshu WangYao He Original Research Open access 26 April 2022 Pages: 1229 - 1242
Clinical Presentation and Outcome of COVID-19 in a Latin American Versus Spanish Population: Matched Case-Control Study Rodrigo AlonsoAna M. CamonHospital Clinic of Barcelona COVID-19 research group Original Research Open access 27 April 2022 Pages: 1243 - 1251
Impact of Valve Culture Positivity on Prognosis in Patients with Infective Endocarditis Who Underwent Valve Surgery Jinnam KimJung Ho KimJoon-Sup Yeom Original Research Open access 30 April 2022 Pages: 1253 - 1265
Combined RT-PCR and Host Response Point-of-Care Testing in Patients Hospitalised with Suspected COVID-19: A Prospective Diagnostic Accuracy Study Nathan J. BrendishAlex R. TannerTristan W. Clark Original Research Open access 09 May 2022 Pages: 1267 - 1280
Clinical Characteristics Associated with Bacterial Bloodstream Coinfection in COVID-19 Nicholas ReboldSara AlosaimyMichael J. Rybak Original Research Open access 11 May 2022 Pages: 1281 - 1296
Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants Rajeev DhereVistasp SethnaRajeshwari Adhiseshan Letter Open access 28 April 2022 Pages: 1297 - 1299
A Response to: Letter to the Editor Regarding “Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants” Johnna PerdrizetEmily K. HornAnna Ong-Lim Letter Open access 26 April 2022 Pages: 1301 - 1303
Correction to: A Dalbavancin Lock Solution Can Reduce Enterococcal Biofilms After Freezing Marta Díaz-NavarroRama HafianMaría Guembe Correction Open access 13 April 2022 Pages: 1305 - 1310
Correction to: Public Health Impact and Cost-Effectiveness Analysis of Routine Infant 4CMenB Vaccination in Germany to Prevent Serogroup B Invasive Meningococcal Disease Stefan ScholzMagdalena SchwarzWolfgang Greiner Correction Open access 13 April 2022 Pages: 1311 - 1311
Correction to: GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia Iris De RyckEleanna SarakinouAudino Podda Correction Open access 18 April 2022 Pages: 1313 - 1313